
The past decade has seen an explosion in our understanding of cancer biology and with it many new potential disease zzso Nonetheless, our ability to translate these advances into therapies is poor, with a failure rate approaching zzso Much discussion has been devoted to this so-called zzso of zzso in zzso drug development, but the problem zzso Could we have overlooked some straightforward explanations to this highly complex problem? Important aspects of tumor zzso drug zzso zzso models, drug delivery, and clinical translation are not often emphasized, but could be zzso This perspective summarizes current views on the problem and suggests feasible zzso 

